Inflammatory diseases of the sinuses: bacteriology and antibiotics.
This article provides an overview of the antimicrobial agents most commonly employed against the bacteria that cause infections in the ear, nose, throat, head, and neck. Because new bacterial resistances appear so regularly, as do new antibiotics, the reader is encouraged to supplement the information provided within this article with current information from the available literature. Specific treatment strategies for both acute and chronic sinusitis also are reviewed.
Fairbanks
D N
DN
George Washington University School of Medicine, Washington, DC.
D000900:Anti-Bacterial Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D005260:Female; D016964:Gram-Negative Anaerobic Cocci / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008297:Male; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy / Q000382:microbiology; D010254:Paranasal Sinus Diseases / Q000188:drug therapy / Q000382:microbiology*; D012852:Sinusitis / Q000188:drug therapy* / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D013297:Streptococcus pyogenes / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents